Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis-Reference-Cited by-同舟云学术

Impaired Antibody Response to the BNT162b2 Messenger RNA Coronavirus Disease 2019 Vaccine in Patients With Systemic Lupus Erythematosus and Rheumatoid Arthritis

Published:2021-07-17 Issue:9 Volume:3 Page:622-628
ISSN:2578-5745
Container-title:ACR Open Rheumatology
language:en
Short-container-title:ACR Open Rheuma

Author:

Ammitzbøll Christian¹²^ORCID,Bartels Lars Erik¹^ORCID,Bøgh Andersen Jakob¹,Risbøl Vils Signe¹^ORCID,Elbæk Mistegård Clara¹²,Dahl Johannsen Anders¹,From Hermansen Marie‐Louise¹,Kragh Thomsen Marianne¹²^ORCID,Erikstrup Christian¹²^ORCID,Hauge Ellen‐Margrethe¹²^ORCID,Troldborg Anne¹²^ORCID

Affiliation:

1. Aarhus University Hospital Aarhus Denmark

2. Aarhus University Aarhus Denmark

Funder

Gigtforeningen

Publisher

Wiley

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/acr2.11299

Reference20 articles.

1. Safety and Efficacy of the BNT162b2 mRNA Covid-19 Vaccine

2. Diagnostic Approach to the Patients with Suspected Primary Immunodeficiency

3. BNT162b2 induces SARS‐CoV‐2‐neutralising antibodies and T cells in humans;Sahin U;medRxiv,2020

4. Antibody responses to the BNT162b2 mRNA vaccine in individuals previously infected with SARS-CoV-2

5. Impact of temporary methotrexate discontinuation for 2 weeks on immunogenicity of seasonal influenza vaccination in patients with rheumatoid arthritis: a randomised clinical trial;Park JK;Ann Rheum Dis,2018

Cited by 72 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Reduced response to SARS-CoV-2 vaccination is associated with impaired immunoglobulin class switch recombination in SLE patients;2024-08-20

2. A Case Report and Literature Review of a Triple-Vaccinated, Rituximab-Treated Systemic Lupus Erythematosus patient with COVID-19 pneumonia;ARP Rheumatology;2024-06-30

3. COVID‐19 Vaccination Before Initiating Rituximab Treatment Induces Strong Serological Response in Autoimmune Rheumatic Disease, Reducing Post‐Pandemic Concerns About the Impact of Rituximab;ACR Open Rheumatology;2024-06-23

4. Clinical disease activity in autoimmune rheumatic patients receiving COVID-19 vaccines;BMC Rheumatology;2024-06-17

5. Immunogenicity and safety of BNT162b2 vaccination in adolescents with systemic lupus erythematosus;Lupus;2024-02-09